Interest Expense in USD of Pelthos Therapeutics Inc. from Q1 2024 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Pelthos Therapeutics Inc. quarterly Interest Expense history and change rate from Q1 2024 to Q3 2025.
Pelthos Therapeutics Inc. Interest Expense for the quarter ending 30 Sep 2025 was $1.35M, a 3351% increase year-over-year.

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Pelthos Therapeutics Inc. Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2025		$1.35M	+$1.31M	+3351%	01 Jul 2025	30 Sep 2025	10-Q	13 Nov 2025
Q1 2025		$1.82K	+$1.82K		01 Jan 2025	31 Mar 2025	10-Q	13 May 2025
Q3 2024		$39K			01 Jul 2024	30 Sep 2024	10-Q	13 Nov 2025
Q1 2024		$0			01 Jan 2024	31 Mar 2024	10-Q	13 May 2025

* An asterisk sign (*) next to the value indicates that the value is likely invalid.